Cogent Biosciences Inc (NASDAQ:COGT) price on Wednesday, May 09, fall -2.06% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.60.
A look at the stock’s price movement, the close in the last trading session was $7.76. Turning to its 52-week performance, $13.50 and $3.67 were the 52-week high and 52-week low respectively. Overall, COGT moved 8.73% over the past month.
Cogent Biosciences Inc’s market cap currently stands at around $726.64 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that COGT is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
COGT’s current price about 12.21% and 12.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 61.15, while 7-day volatility ratio is 5.98% and 6.46% in the 30-day chart. Further, Cogent Biosciences Inc (COGT) has a beta value of 1.60, and an average true range (ATR) of 0.48.
If we refocus on Cogent Biosciences Inc (NASDAQ:COGT), historical trading data shows that trading volumes averaged 2.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 86.12 million shares.
The 11.55% of Cogent Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 80.29% of the company’s shares. Current price change has pushed the stock 29.25% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the COGT stock continues to rise going into the next quarter.
